Brief: Cyclo Therapeutics Entered Into A Fifth Amended And Restated Note Purchase Agreement
08/11/2024 11:13
Nov 8 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS : ENTERED INTO A FIFTH AMENDED AND
RESTATED
NOTE PURCHASE AGREEMENT
* CYCLO THERAPEUTICS: UNDER AGREEMENT, ISSUED & SOLD
CONVERTIBLE
PROMISSORY NOTE IN AMOUNT OF $2 MILLION TO RAFAEL HOLDINGS
* CYCLO THERAPEUTICS : NOTE MATURES ON DECEMBER 21
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug